about
Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cellsThe extracellular matrix microtopography drives critical changes in cellular motility and Rho A activity in colon cancer cells.Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetesPlacental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility.Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylates.Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.Enrichment of IL-17A+ IFN-γ+ and IL-22+ IFN-γ+ T cell subsets is associated with reduction of NKp44+ ILC3s in the terminal ileum of Crohn's disease patients.Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 DiabetesPhosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide's morphogenic properties.Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn's disease: a case report.Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing.Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.Vedolizumab: a novel medical intervention in the treatment of primary sclerosing cholangitis.Oesophageal mastocytosis: eosinophilic oesophagitis without eosinophils?Successful targeted treatment of mast cell activation syndrome with tofacitinib.Coming full circle: an impressive case of Crohn's disease.Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD.Incorporation of Scribes Into the Inflammatory Bowel Disease Clinic Improves Quality of Care and Physician Productivity.Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide.The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn's disease.Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional SupportQuantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel diseaseTransient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodelingVedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel DiseaseErratum to: Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal HealingSTAT3 Genotypic Variant rs744166 and Increased Tyrosine Phosphorylation of STAT3 in IL-23 Responsive Innate Lymphoid Cells during Pathogenesis of Crohn's Disease
P50
Q27302396-6CDF6A31-6CD9-4814-A20D-CA6D5212FB87Q34057537-F03424C9-6F44-4DDF-88C2-B51829872170Q35055599-CB87681B-856B-4FD1-BDA6-3F0C68A8A12CQ37554366-72DD3C91-A8F0-4759-947E-81EB127754A5Q38009308-2B573C15-F118-4C94-B27B-3607331FC3E1Q38201107-01198E39-EC15-4079-A96A-CCBB68D9CD27Q38376287-E7FFB8B2-F67B-43D8-AF8B-5235714D2147Q38741014-1594C535-2644-4356-A5C5-2EF4DCFF3D78Q39001036-6F201535-21F3-4E4B-9224-0BEFFF965452Q40586929-27F8F2ED-8598-4705-A2B0-6D02A4770F92Q41167342-C31B7246-3ED7-49FE-A71C-42B0323D0367Q42319901-19947FE0-4D70-4502-8751-EEDE90F91309Q47132433-223C018E-D048-4B3C-97A1-4D038EA25C70Q48148347-E92B59BF-8BD0-4B13-8060-E72E8C588ADFQ48160384-667E84D6-5423-4C20-98BD-93B3B7738878Q48314019-99C4FD7E-9E2B-4834-99BD-AAF5FD56634FQ49328287-98ECAC36-7771-4B45-B663-CAA49DA93CF8Q50098206-516816E6-4CD0-4BF5-B494-523D0730E0F6Q52692528-7000C758-38DD-464C-9E80-D6F06681DD8BQ52766739-5E86F0CB-6E5B-4970-8A1F-AF9A0EC1C8E6Q53095998-E54C2D2D-41DE-413D-AB0A-E07AE1EFA14AQ57821771-FDB77590-82BE-4D35-BEE6-8019ED673EF8Q61172884-D79A243E-42C9-47E3-B1E8-8484ACC32BCBQ81742336-82B7427A-6EC0-47D7-AE21-1B696B8BA2E9Q89511124-9E1F09A4-D23A-440F-8030-CA103021BFC9Q89925451-948E7BA0-2CC3-4A41-A532-BE27B302755AQ92007692-30B6D5E4-CE43-440D-B68F-192D20FA3252
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sarah C Glover
@ast
Sarah C Glover
@en
Sarah C Glover
@es
Sarah C Glover
@nl
type
label
Sarah C Glover
@ast
Sarah C Glover
@en
Sarah C Glover
@es
Sarah C Glover
@nl
prefLabel
Sarah C Glover
@ast
Sarah C Glover
@en
Sarah C Glover
@es
Sarah C Glover
@nl
P1153
P106
P1153
57158921400
57191579250
7103344818
P21
P31
P496
0000-0002-9899-0473